menu
    • menu

    Company profile for Bloom Science

    NEW Drugs in Dev: 1
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Bloom Science, a private company, is developing transformational medicines that target diseases in neurology and oncology. Our discovery platform starts with positive clinical outcomes that elucidates novel connections between these clinical outcomes, the microbiome, and critical disease pathways to accelerate drug discovery and deliver meaningful solutions to patients in the timely manner.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Bloom ScienceUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Del Mar Heights Rd, San Diego, CA 92130, US
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://bloomscience.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/bloomscience/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Bloom Science Launches Phase 1B Trial of BL-001
    Bloom Science Launches Phase 1B Trial of BL-001

    24 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/bloom-science-initiates-phase-1b-obesity-trial-of-bl-001-advancing-a-differentiated-approach-beyond-glp-1-302694371.html

    PR NEWSWIRE
    24 Feb 2026
    Share Share
    Bloom Science Reports Positive Data from Phase 1 Trial of BL-001
    Bloom Science Reports Positive Data from Phase 1 Trial of BL-001

    04 Mar 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/bloom-science-reports-positive-data-from-phase-1-trial-of-bl-001-demonstrating-statistically-significant-durable-weight-loss-in-overweight-individuals-302391446.html

    PR NEWSWIRE
    04 Mar 2025
    Share Share
    Bloom Science Announces Positive Data from a Phase 1 Clinical Trial of BL-001
    Bloom Science Announces Positive Data from a Phase 1 Clinical Trial of BL-001

    17 Aug 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/bloom-science-announces-positive-topline-data-from-a-phase-1-clinical-trial-of-bl-001-a-potential-first-in-class-therapeutic-being-developed-for-both-dravet-syndrome-and-als-301903352.html

    PR NEWSWIRE
    17 Aug 2023
    Share Share
    Bloom Completes Enrollment in Ph 1 Trial of BL-001, a First-in-Class Therapy
    Bloom Completes Enrollment in Ph 1 Trial of BL-001, a First-in-Class Therapy

    25 Apr 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/bloom-science-completes-enrollment-in-phase-1-trial-of-bl-001-a-first-in-class-therapy-being-developed-for-dravet-syndrome-301806574.html

    PR NEWSWIRE
    25 Apr 2023
    Share Share
    Bloom Science Raises USD $12 Million in Series A Financing
    Bloom Science Raises USD $12 Million in Series A Financing

    09 Dec 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/bloom-science-raises-usd-12-million-in-series-a-financing-824935685.html

    PRNEWSWIRE
    09 Dec 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search